Rule 36 India Import in Jordan

How the rule 36 india import pathway operates in Jordan.

About Rule 36 India Import

India's personal-use import pathway under Rule 36 of D&C Rules.

How Rule 36 India Import works in Jordan

Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.

Patients in Jordan seeking access under Rule 36 India Import typically follow this flow: a licensed physician in Jordan issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Jordan

  • Physician prescription and clinical-justification letter.
  • Patient identification and consent.
  • Country-specific NPP/personal-import form.
  • Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Rule 36 India Import in Jordan

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp